Use of Sodium-Glucose Cotransporter-2 Inhibitor for Diabetes Management in Patients Following Kidney Transplantation

Erica F. Crannage, Katherine L. Nguyen, Morgan D. Ellebrecht, Laura M. Challen, Andrew J. Crannage

Research output: Contribution to journalReview articlepeer-review

Original languageEnglish
Pages (from-to)147-155
Number of pages9
JournalJournal of Pharmacy Technology
Volume39
Issue number3
DOIs
StatePublished - Jun 2023

ASJC Scopus Subject Areas

  • Pharmaceutical Science

Keywords

  • canagliflozin
  • dapagliflozin
  • diabetes mellitus
  • empagliflozin
  • kidney transplant
  • posttransplantation diabetes
  • sodium-glucose cotransporter-2

Cite this